Anne Samuel
Stock Analyst at JP Morgan
(1.99)
# 2,475
Out of 5,099 analysts
67
Total ratings
54.55%
Success rate
-0.09%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $13 → $7 | $3.88 | +80.41% | 13 | Nov 17, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $125 → $126 | $95.73 | +31.62% | 9 | Sep 3, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $229.16 | +26.55% | 7 | Aug 28, 2025 | |
| PGNY Progyny | Maintains: Neutral | $23 → $25 | $25.17 | -0.68% | 8 | Aug 26, 2025 | |
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $45.04 | +33.21% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $222.92 | -20.60% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $43.97 | -18.13% | 5 | Mar 20, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $15.78 | +77.44% | 2 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $23.64 | -11.17% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $2.64 | +392.42% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $30.40 | -11.18% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $2.38 | +110.08% | 1 | Jul 31, 2024 |
Evolent Health
Nov 17, 2025
Maintains: Overweight
Price Target: $13 → $7
Current: $3.88
Upside: +80.41%
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $95.73
Upside: +31.62%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $229.16
Upside: +26.55%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $25.17
Upside: -0.68%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $45.04
Upside: +33.21%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $222.92
Upside: -20.60%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $43.97
Upside: -18.13%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $15.78
Upside: +77.44%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $23.64
Upside: -11.17%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $2.64
Upside: +392.42%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $30.40
Upside: -11.18%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $2.38
Upside: +110.08%